Y.ora Vision, Inc., a newly established ophthalmic medical device company and a spoke company of Eyexora, has officially announced the signing of a licensing agreement between the Singapore Eye Research Institute (SERI) and Eyexora Global. The agreement is set to…
hape Memory Medical Inc., developer of the only commercially available volume-expanding shape memory polymer for endovascular embolization, has announced that it has reached 50% enrollment in its ongoing AAA-SHAPE Pivotal Trial. This milestone marks the successful treatment of the 90th…
Delix Therapeutics, a clinical-stage neuroscience company advancing a new generation of non-hallucinogenic neuroplastogens for the treatment of serious neuropsychiatric and neurodegenerative disorders, has announced the publication of a peer-reviewed study in ACS Chemical Neuroscience. The paper, titled “Zalsupindole is a…
AeroFarms, a global pioneer in indoor vertical farming and the leading supplier of microgreens to the U.S. retail market, has announced the results of an independent third-party study validating the exceptional nutritional value of its Micro Broccoli. The findings demonstrate…
Arcitecta, a pioneer in innovative data management software, recently joined leading research institutions and technology partners—including Spectra Logic, Wasabi, Cerabyte, and IQM—at the inaugural DATAKAMER 2025 event. Hosted by the Dana-Farber Cancer Institute in Boston, Massachusetts, this exclusive, one-day forum…
At the American Society of Human Genetics (ASHG) 2025 industry session, Oxford Nanopore Technologies announced a series of major updates aimed at advancing translational and clinical human genetics. The company’s new developments are designed to help researchers and clinicians achieve…
Liberate Bio, Inc., a biotechnology innovator advancing next-generation genetic medicines that deliver RNA therapies directly to immune cells, has announced groundbreaking preclinical data presented at the American Society of Gene and Cell Therapy’s (ASGCT) Advancing Cell and Gene Therapies for…
Scanogen Inc., a molecular diagnostics company at the forefront of next-generation infectious disease detection, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its rapid assay designed to identify bloodstream infection pathogens directly from…
ClearB Therapeutics, Inc., a clinical-stage biotechnology company dedicated to developing therapies aimed at achieving functional cure in patients with chronic hepatitis B (CHB) infection, announced that the sentinel subject safety review in their ongoing Phase 1b study of CLB-4000 supports…
Svante, a global leader in solid sorbent-based carbon capture and removal filter technology, celebrated the announcement of the 2025 Nobel Prize in Chemistry, awarded to scientists Susumu Kitagawa, Richard Robson, and Omar Yaghi for their pioneering work in the metal-organic…